Morgan Stanley is out with a research report on Lionbridge Technologies LIOX and is downgrading shares to Hold with a $2.75 price target on shares.
In a note to clients, Morgan Stanley writes, "2Q results suggest LIOX may be turning the corner in terms of operational performance, but we think investors may be inclined to wait for more supporting data points before warming up to the stock. Restructuring actions are finally starting to tail off, but the core translation/localization business remains prone to lumpiness tied to clients' somewhat unpredictable product cycles. Assume coverage with Hold rating (was Buy previously)."
Shares of LIOX lost 10 cents on Friday to close at $2.58.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in